The team consists of a professor Raghavan Varadarajan, DR.
The grant, the amount of which has not been disclosed, supports the research done by them for initial development in India the technology platform and reagents required to develop, manufacture and test novel mRNA vaccines, ILSF said.
“We hope that your work will lay the foundation for India’s ability to respond quickly to future pandemics and improve our ability to respond to new variants of SARS-CoV-2,” it said.
“The grant is valid for three years and will fund research into the development of platform technologies for the development of mRNA vaccines,” said a statement on Monday by the ILSF, which was founded by professional scientists, academics and entrepreneurs.
According to the professor Shahid Jameel (Member of the Scientific Advisory Board, ILSF), mRNA Vaccine development technology is important for India to provide a quick and effective response to future pandemics, and the successful completion of this project will enable the creation of much-needed capacity for mRNA vaccine development in India.
“Investigators are not just involved in developing a vaccine against new variants of SARS-CoV-2, but also attempts to develop methods of making thermostable RNA vaccines that would be vital for resource-poor tropical regions of the world, ”he said.
(This story was not edited by Devdiscourse staff and is automatically generated from a syndicated feed.)